Board
Mr Richard Davis
Independent Chairman
Mr. Richard Davis joined the Group in June 2014 and is currently serving as a non-executive director of ASX listed companies, InvoCare Limited and Australian Vintage Limited (and Chairman of Australian Vintage).
Richard worked for InvoCare for 20 years until 2008. For the majority of that time he held the position of CEO and managed the growth of that business through a number of ownership changes and over 20 acquisitions, including offshore in Singapore.
Prior to InvoCare Limited, Richard worked in venture capital and as an accounting partner of Bird Cameron. Richard holds a Bachelor of Economics from the University of Sydney.
Ms Catherine Aston
Independent Non-executive Director
Cathy Aston was appointed non-executive director of Monash IVF Group on 26 February 2024. She is an experienced non-executive director / Chair of listed and unlisted entities covering technology, financial services, marketing services, health, and government across Australia and Asia. She has a broad commercial background with senior roles in finance, marketing, and strategy, including as CFO for Telstra International and the Chief Executive Officer of a mobile joint venture in Sri Lanka.
Cathy is currently a non-executive director of Macquarie Investment Management Ltd (Chair of the Audit, Risk and Compliance Committee), IVE Group Ltd (Chair of the Audit and Risk Committee) and IMB Bank Ltd (Chair). Cathy’s advisory roles have included working with NSW State Government and serving as an advisory board member of Avanseus Pty Ltd, a Singapore-based AI business. Previous listed board roles include Integrated Research Ltd, Virtus Health Ltd, and Over the Wire Ltd.
She holds a Bachelor of Economics from Macquarie University and a Master of Commerce (Accounting and Legal Studies) from the University of NSW. She is a Graduate Member of the Australian Institute of Company Directors and a Senior Fellow of the Financial Services Institute of AustralAsia (FINSIA).
Mr Neil Broekhuizen
Independent Non-executive Director
Mr Neil Broekhuizen is the Joint Chief Executive Officer of Ironbridge.
Neil has 25 years of private equity experience with Investcorp and Bridgepoint in Europe and Ironbridge in Australia. Neil has sat on the Ironbridge Investment Committee since inception and also represents the Ironbridge Funds on the Board of Bravura Solutions.
Neil is qualified as a Chartered Accountant and holds a BSC (Eng) Honours degree from Imperial College, University of London.
Mr Josef Czyzewski
Independent Non-executive Director
Mr Josef Czyzewski joined the Group in June 2014 and has over 30 years of experience in senior finance positions and significant experience in the health industry.
Josef has held the positions of CFO at Healthscope Limited, and more recently CFO/General Manager Strategy and Development at Spotless Group Limited following its takeover by private equity interests in 2012.
Prior to that time, Josef has held various senior finance positions with BHP Billiton including VP Finance and Corporate Treasurer. He holds a Bachelor of Commerce from the University of Newcastle and is a Graduate Member of the Australian Institute of Company Directors.
Dr Richard Henshaw
Executive Director
Dr Richard Henshaw MD FRANZCOG FRCOG has practiced in the field of reproductive medicine since 1995.
Richard works as a Fertility Specialist for the Group.
Richard has served on many national bodies, including RANZCOG Council, the IVF Medical Directors group pf Australia and New Zealand, and the Reproductive Technology Accreditation Committee.
Ms Zita Peach
Independent Non-executive Director
Ms Peach has more than 25 years of commercial experience in the pharmaceutical, biotechnology, medical devices and health services industries.
She worked for major industry players such as CSL Limited and Merck Sharp &Dohme, the Australian subsidiary of Merck Inc.
Ms Peach’s most recent executive position was as the Managing Director for Australia and New Zealand and Executive Vice President, South Asia Pacific for Fresenius Kabi, a leading provider of pharmaceutical products and medical devices to hospitals. Previously, Ms Peach was Vice President, Business Development, for CSL Limited, a position she held for ten years.
Ms Peach is a Non-Executive Director of the ASX-listed AirXpanders, Inc., Starpharma Holdings Limited, Pacific Smiles Group Limited and Visioneering Technologies, Inc. Ms Peach is also a member of the Hudson Institute of Medical Research Board.
Ms Peach is a Fellow of the Australian Institute of Company Directors and a Fellow of the Australian Marketing Institute.
Ms Catherine West
Independent Non-executive Director
Catherine West was appointed Non-executive Director to Monash IVF Group on 8 September 2020. She is an experienced ASX listed non-executive director and has over 25 years of legal, business affairs and strategy experience in customer focused businesses in the media, entertainment, telecommunications and medical sectors in Australia, the UK and Europe.
Catherine’s expertise covers commercial arrangements, corporate transactions and joint ventures, intellectual property, regulatory policy, media and advertising, consumer issues, remuneration, risk management, corporate governance and compliance.
Catherine is a non-executive director of ASX listed Nine Entertainment where she is Chair of the People and Remuneration Committee and a member of the Audit and Risk Committee. She was previously on the board of Southern Phone, a regional telecommunications company, before its successful sale to AGL. She is a Vice-President of the Sydney Breast Cancer Foundation at Chris O’Brien Lifehouse, a director of the NIDA Foundation and a Governor of Wenona School. She is also a consultant to the healthcare sector and to media companies internationally.
She holds a Bachelor of Laws (Hons) and a Bachelor of Economics from the University of Sydney. She is a Graduate Member of the Australian Institute of Company Directors.
Mr Michael Knaap
Chief Executive Officer and Managing Director
Mr Michael Knaap was appointed to the role of Chief Executive Officer and Managing Director for Monash IVF Group on 15 April 2019.
Following his tenure as MVF Group’s Chief Financial Officer and Company Secretary since August 2015, Michael was appointed to Interim CEO in Oct 2018.
Mr Knaap has nearly 20 years experience in executive positions with a strong operational, strategic and leadership background. Prior to joining MVF Group, Michael was with Patties Foods Limited where he held a number of executive positions over six years, including the role of Chief Financial Officer and Company Secretary.
He holds a Bachelor of Accounting from Monash University and is a Certified Practising Accountant.